Sunday, March 20 2022
Many drug companies are developing gene-based treatments for sickle cell and beta thalassemia, a related blood disorder. But Novartis and Precision say they still see a need for treatments that can work inside the body, rather than via stem cells edited in a laboratory, and can be deployed in countries where stem cell transplants can’t be easily carried out.
Thursday, March 10 2022
The European Sickle Cell Federation officially launches its global campaign “Sickle Cell Has No Colour.. It’s in the Blood”, on World Sickle Cell Day june 19th 2022.
Find more information on this campaign and the press release here.